|
1 Elwood PC, Cochrane AL, Burr M et al. A randomised controlled trial of acetylsalicylic acid in the secondary prevention of mortality from myocardial infarction. BMJ 1974; 436-40.
2Antiplatelet Trialists’ Collaboration. Collaborative overview of randomised trials of antiplatelet therapy I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of people. BMJ 1994; 308: 81-106.
3 Prentice CRM, Collins R, Rodgers A, MacMahon S, for the PEP trial investigators. The Pulmonary Embolism Prevention (PEP) trial: effects of low dose aspirin on major vascular events in hip fracture surgical patients. Blood Coagulation and Fibrinolysis 1999; 10(8):532. Also Lancet: In Press.
4 Hughes GRV. Thrombosis, abortion, cerebral disease and the lupus anticoagulant.
|